Rosenbluth J, Liang W L, Schiff R, Dou W K
Department of Physiology and Neuroscience, Rusk Institute of Rehabilitation Medicine, New York University School of Medicine, New York 10016, USA.
Glia. 1997 Jan;19(1):58-66. doi: 10.1002/(sici)1098-1136(199701)19:1<58::aid-glia6>3.0.co;2-6.
It was shown previously (Rosenbluth et al.: J. Neurosci. 16:2635-2641, 1996) that implantation of hybridoma cells that produce an IgM antigalactocerebroside into the spinal cord of young rats results in the development of myelin sheaths with a repeat period approximately 2-3x normal, similar to the abnormal peripheral myelin sheaths seen in human IgM gammopathies. We now present evidence that this effect can be reproduced in the spinal cord by implanting either of two other hybridomas, O4 and A2B5, that secrete, respectively, antisulfatide and antiganglioside IgM antibodies. The formation of expanded CNS myelin thus does not depend on antibodies to galactocerebroside specifically but can be mediated by IgM antibodies that react with other myelin glycolipids as well.
先前的研究(Rosenbluth等人:《神经科学杂志》16:2635 - 2641,1996年)表明,将产生抗半乳糖脑苷脂IgM的杂交瘤细胞植入幼鼠脊髓会导致髓鞘形成,其重复周期约为正常的2 - 3倍,类似于人类IgM丙种球蛋白病中所见的异常外周髓鞘。我们现在提供证据表明,通过植入另外两种杂交瘤O4和A2B5中的任何一种,这种效应都可以在脊髓中重现,这两种杂交瘤分别分泌抗硫脂和抗神经节苷脂IgM抗体。因此,中枢神经系统中扩张性髓鞘的形成并不特别依赖于抗半乳糖脑苷脂抗体,而是可以由与其他髓鞘糖脂发生反应的IgM抗体介导。